Cancer pain control possible with gene therapy
Mouse studies indicate successful pain relief, University of Pittsburgh researchers say
By “programming” a herpes simplex virus to deliver a gene-mediated pain-blocking protein at the cellular level, University of Pittsburgh researchers have been able to significantly reduce cancer-related pain in mice with tumors, the researchers report in the November issue of the journal Annals of Neurology. The paper, “Herpes vector-mediated expression of proenkephalin reduces bone cancer pain,” is now available online at the journals Web site, http://www.interscience.wiley.com/jpages/0364-5134/.
“Chronic pain is notoriously difficult to treat effectively,” said co-author Joseph Glorioso, Ph.D., chairman of the department of molecular genetics and biochemistry and director of the Molecular Medicine Institute at the University of Pittsburgh School of Medicine, and president of the American Society of Gene Therapy. “Weve been able to show that using this virus can significantly reduce bone cancer pain – at least in mice.”
The investigators are pursuing necessary approvals to begin a clinical trial in patients with severe pain resulting from metastatic cancer, and hope to start enrolling patients sometime next year.
“We are excited about the possibility that this approach may help to control pain in patients who cant get complete relief from the maximum current treatment,” said senior author David Fink, M.D., professor of neurology and molecular genetics and biochemistry at the University of Pittsburgh School of Medicine and chief of neurology and director of the Geriatric Research Education and Clinical Center at the Veterans Administration Pittsburgh Healthcare System.
Drs. Fink, Glorioso and their colleagues created an inactivated herpes simplex virus that carries the human gene for proenkaphalin, a naturally occurring painkilling peptide, a combination of amino acids.
Mice with tumors in a leg bone that received injections with the altered virus showed a substantial and significant reduction in pain-related behavior, the authors report.
“Although we have many powerful medications to treat pain, unwelcome side effects of these drugs limit our ability to relieve the most severe painful conditions,” said Dr. Fink. “Using the virus to deliver the natural painkilling peptide may help in those cases.”
These undesirable side effects can include excessive drowsiness, constipation and difficulty urinating.
“It remains to be seen how effective this may be in humans,” said Dr. Glorioso. “But what we have seen so far is encouraging.”
In addition to Drs. Fink and Glorioso, other authors include James Goss, Ph.D.; Marina Mata, M.D.; Cara Harley, B.S.; Xiaoping Hu and William Goins, Ph.D.
Additional Contact:
Michele D. Baum
Alan Aldinger
PHONE: (412) 647-3555
FAX: (412) 624-3184
E-MAIL:
BaumMD@upmc.edu
AldiAL@upmc.edu
Media Contact
All latest news from the category: Health and Medicine
This subject area encompasses research and studies in the field of human medicine.
Among the wide-ranging list of topics covered here are anesthesiology, anatomy, surgery, human genetics, hygiene and environmental medicine, internal medicine, neurology, pharmacology, physiology, urology and dental medicine.
Newest articles
First-of-its-kind study uses remote sensing to monitor plastic debris in rivers and lakes
Remote sensing creates a cost-effective solution to monitoring plastic pollution. A first-of-its-kind study from researchers at the University of Minnesota Twin Cities shows how remote sensing can help monitor and…
Laser-based artificial neuron mimics nerve cell functions at lightning speed
With a processing speed a billion times faster than nature, chip-based laser neuron could help advance AI tasks such as pattern recognition and sequence prediction. Researchers have developed a laser-based…
Optimising the processing of plastic waste
Just one look in the yellow bin reveals a colourful jumble of different types of plastic. However, the purer and more uniform plastic waste is, the easier it is to…